Are Options Traders Bullish on ADMS?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon
Adamas Pharmaceuticals Inc.

ADMS

19.05

-0.12

-0.6%

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About ADMS

Adamas Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on those affected by chronic disorders of the central nervous system. The company achieves this by modifying the pharmacokinetic profiles of approved drugs to create novel therapeutics for use alone or in fixed-dose combination products. Adamas is currently developing its lead wholly-owned product candidate, ADS-5102, for a complication associated with the treatment of Parkinson's disease known as levodopa-induced dyskinesia, or LID, and is evaluating other potential indications. The company's portfolio also includes two approved products with Forest Laboratories Holdings Limited (a subsidiary of Actavis plc), Namzaric(TM) and Namenda XR(R). Forest is responsible for marketing both products in the United States under an exclusive license from Adamas. For more information, please visit www.adamaspharma.com.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ADMS is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 373.0 M 3.72957E+08 202 202 0.02% 0.000228878 190 K 190090
EQWS Invesco Russell 2000 Equal Weight ETF 26.2 M 2.62E+07 1,968 1968 0.02% 0.00021 5 K 5387
FHLC Fidelity MSCI Health Care Index ETF 1.5 B 1.5E+09 350 350 0.01% 0.000100042 147 K 146518
IBB iShares Nasdaq Biotechnology Index Fund 9.4 B 9.38071E+09 191 191 0.06% 0.0006 6.1 M 6075470
ITOT iShares Core S&P Total U.S. Stock Market ETF 16.1 B 1.60928E+10 3,416 3416 0.0% 0 367 K 367465
IWC iShares Microcap ETF 1.1 B 1.11424E+09 1,459 1459 0.1% 0.001 1.1 M 1085830
IWM iShares Russell 2000 ETF 47.1 B 4.71068E+10 2,043 2043 0.02% 0.0002 8.8 M 8754310
IWN iShares Russell 2000 Value ETF 10.3 B 1.03294E+10 1,390 1390 0.02% 0.0002 1.9 M 1915950
IWO iShares Russell 2000 Growth ETF 11.1 B 1.10525E+10 1,254 1254 0.02% 0.0002 2.0 M 2016840
IWV iShares Russell 3000 ETF 9.1 B 9.12779E+09 3,026 3026 0.0% 0 122 K 122170
SBIO ALPS Medical Breakthroughs ETF 273.3 M 2.73324E+08 113 113 0.34% 0.0034 929 K 929302
UBIO Proshares UltraPro Nasdaq Biotechnology 34.7 M 3.4668E+07 196 196 0.01% 0.000128165 15 K 14761
URTY ProShares UltraPro Russell2000 156.8 M 1.56818E+08 2,054 2054 0.0% 2.87362E-05 16 K 15585
UWM ProShares Ultra Russell2000 258.3 M 2.5827E+08 2,054 2054 0.01% 6.43691E-05 37 K 36921
XBI SPDR Series Trust SPDR S&P Biotech ETF 5.8 B 5.81096E+09 120 120 0.68% 0.00679669 39.7 M 3.969535E+07
FAD First Trust Multi Cap Growth AlphaDEX Fund 219.1 M 2.19062E+08 675 675 0.04% 0.0004 88 K 87625
FYC First Trust Small Cap Growth AlphaDEX Fund 479.8 M 4.79777E+08 262 262 0.18% 0.0018 864 K 863599
FYX First Trust Small Cap Core AlphaDEX Fund 791.7 M 7.91707E+08 525 525 0.09% 0.0009 713 K 712536

Wait, Before You Leave...